Tender detail
Non-exclusive pharmaceutical discount agreements for FAM CERNEVIT and interchangeable finished medicinal products
Summary
The procurement concerns non-exclusive pharmaceutical discount agreements for medicinal products containing the active substance FAM CERNEVIT, excluding KPG, and interchangeable finished medicinal products under ATC code B05XC30. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The agreements are intended to run from 1 October 2026 to 30 September 2028, but will end automatically when an exclusive agreement for the same active substance enters into force. Precise participation and submission requirements were not included in the machine-readable notice and must be checked in the official tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.